Претраживање
Приказ резултата 31-40 од 175
Development and Validation of an HPLC Method for Determination of Ziprasidone and Its Impurities in Pharmaceutical Dosage Forms
(AOAC Int, Gaithersburg, 2011)
Ziprasidone is known as a novel "atypical" or "second-generation" antipsychotic drug. A sensitive and reproducible method was developed and validated for determination of ziprasidone and its major impurities, which are ...
Phenotypes and serum level of alpha-1-antitrypsin in lung cancer
(Balkan Union of Oncology (B.U.ON.), 2011)
Propose: Alpha-1-antitrypsin (AAT) as the major circulating inhibitor of proteases has important role in protease-antiprotease homeostasis. Recent studies have confirmed its antiapoptotic role. AAT is a highly polymorphic ...
Drug influence on appetite and body weight / Uticaj lekova na apetit i telesnu masu
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
It is said that developed world, as well as countries in transition are experiencing an "epidemic of obesity". Iatrogenic obesity may contribute to this issue. The scope of this paper is common used drugs with orexigenic ...
Statistical and machine learning tools in evaluation and optimization of modified release products
(Elsevier Science BV, Amsterdam, 2011)
Serum high sensitive c-reactive protein level in normal pregnancy and his association with body mass index
(Walter de Gruyter & Co, Berlin, 2011)
Is there a need for a hospital pharmacist specialisation
(Pharma Publishing & Media Europe-Ppm Europe, Mol, 2011)
Cytotoxicity and antimicrobial activity of Teucrium scordium L. (Lamiaceae) extracts
(Academic Journals, Victoria Island, 2011)
Cytotoxicity and antimicrobial activity of cyclohexane, dichlormethane and methanol extracts of Teucrium scordium subspec. scordioides was studied. Cyclohexane and dichlormethane extracts of T. scordium possessed high ...
Evaluation of Single-Point Sampling Strategies for the Estimation of Moclobemide Exposure in Depressive Patients
(Wiley, Hoboken, 2011)
Because moclobemide pharmacokinetics vary considerably among individuals, monitoring of plasma concentrations lends insight into its pharmacokinetic behavior and enhances its rational use in clinical practice. The aim of ...
How to remove barriers to medicines trade in emerging economies: the role of medicines regulatory authority in Serbia
(Springer, New York, 2011)
The primary role of European pharmaceutical legislation is to safeguard public health while encouraging the development of the pharmaceutical industry, creation of single market for pharmaceuticals with removed barriers ...